Search Results - "Jahnke, Natalie"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Tenofovir-Based Rescue Therapy for Advanced Liver Disease in 6 Patients Coinfected with HIV and Hepatitis B Virus and Receiving Lamivudine by Gutiérrez, Sonia, Guillemi, Silvia, Jahnke, Natalie, Montessori, Valentina, Harrigan, P. Richard, Montaner, Julio S. G.

    Published in Clinical infectious diseases (01-02-2008)
    “…We summarize the clinical history and laboratory results following the introduction of tenofovir among 6 patients coinfected with human immunodeficiency virus…”
    Get full text
    Journal Article
  2. 2

    Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients by PHILLIPS, Elizabeth, GUTIERREZ, Sonia, JAHNKE, Natalie, YIP, Benita, LIMA, Viviane D, HOGG, Robert S, HARRIGAN, P. Richard, MONTANER, Julio S. G

    Published in AIDS (London) (31-07-2007)
    “…To assess risks factors and outcomes associated with nevirapine hypersensitivity reactions, and to determine the effect of hypersensitivity as a modifier of…”
    Get full text
    Journal Article
  3. 3

    Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens by MONTANER, Julio S. G, HARRIGAN, P. Richard, JAHNKE, Natalie, RABOUD, Janet, CASTILLO, Eliana, HOGG, Robert S, YIP, Benita, HARRIS, Marianne, MONTESSORI, Val, O'SHAUGHNESSY, Michael V

    Published in AIDS (London) (05-01-2001)
    “…To characterize the antiviral response and tolerability of a multi-drug rescue therapy (MDRT) among heavily pretreated patients. Observational study conducted…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy by WOOD, Evan, YIP, Benita, HOGG, Robert S, SHERLOCK, Christopher H, JAHNKE, Natalie, HARRIGAN, Richard P, O'SHAUGHNESSY, Michael V, MONTANER, Julio S. G

    Published in AIDS (London) (08-09-2000)
    “…To characterize the relationship between plasma viral load (pVL) suppression and triple drug antiretroviral therapy, and the accompanying changes in CD4 cell…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Antiretroviral effect of two different dose regimens of ritonavir and saquinavir on HIV-infected adults in a population-based setting by Jahnke, N, Seminari, E, Hogg, R S, Yip, B, O'Shaughnessy, M V, Montaner, J S

    Published in Antiviral therapy (01-01-1999)
    “…To characterize the antiviral effect and tolerability of higher dose (HD, 600 mg two times daily) and lower dose (LD, 400 mg two times daily) combination…”
    Get full text
    Journal Article
  8. 8

    Perfil lipídico de pacientes com alto risco para eventos cardiovasculares na prática clínica diária by Moreira, Rodrigo O., Santos, Raul D., Martinez, Lilton, Saldanha, Fabiana C., Pimenta, Jara Lucia A.C., Feijoo, Josefina, Jahnke, Natalie, Mangile, Otávio C., Kupfer, Rosane

    “…Embora existam recomendações especificas envolvendo o tratamento das dislipidemias em pacientes com alto risco, estas recomendações dificilmente são seguidas…”
    Get full text
    Journal Article
  9. 9

    Lipid profile of patients with increased risk for cardiovascular events in daily clinical practice by Moreira, Rodrigo O, Santos, Raul D, Martinez, Lilton, Saldanha, Fabiana C, Pimenta, Jara Lucia A C, Feijoo, Josefina, Jahnke, Natalie, Mangile, Otávio C, Kupfer, Rosane

    “…Although there are specific guidelines regarding the treatment of dyslipidemia in highly risk patients, these recommendations are usually inadequately…”
    Get full text
    Journal Article
  10. 10

    Perfil lipídico de pacientes com alto risco para eventos cardiovasculares na prática clínica diária by Moreira, Rodrigo O., Santos, Raul D., Martinez, Lilton, Saldanha, Fabiana C., Pimenta, Jara Lucia A.C., Feijoo, Josefina, Jahnke, Natalie, Mangile, Otávio C., Kupfer, Rosane

    “…Embora existam recomendações especificas envolvendo o tratamento das dislipidemias em pacientes com alto risco, estas recomendações dificilmente são seguidas…”
    Get full text
    Journal Article